Veracyte (VCYT)

• Market cap: $2.78B
• 1 day: -2.33%
• 5 days: -1.46%
• 1 month: -19.1%
• 3 months: -16.9%
• 6 months: 22.18%
• Year to date: -17.08%
• 1 year: -12.95%
• 5 years: -53.59%
• 10 years: 527.68%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Employees: 824